评论:获取幻觉药物治疗生命结束时的心理痛苦 - 优先考虑我们的优先事项
Daniel Rosenbaum1, Sarah Hales2, Daniel Z Buchman3
1Psychiatrist and Clinician Investigator, Nikean Psychedelic Psychotherapy Research Centre, University Health Network, Lecturer, Department of Psychiatry, University of Toronto, Toronto, ON.
生命末期的心理痛苦需要政策关注. 虽然迷幻疗法显示出前景,但优先考虑公平获得整体息护理至关重要,以避免从经过验证的计划中转移资源.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 迷幻疗法 迷幻疗法
- 卫生政策 卫生政策
背景情况:
- 生命末期的心理痛苦是一个重要的公共卫生问题,需要政策考虑.
- 在这种临床背景下,迷幻疗法正在成为一种潜在的治疗方法.
研究的目的:
- 批判性地评估心理治疗对生命末期心理痛苦的政策影响.
- 倡导一种平衡的方法,以解决在息护理获取方面存在的不平等问题.
主要方法:
- 这是一个反驳,为现有的研究和政策讨论提供了批判性的视角.
- 对临终护理中迷幻疗法的现有证据基础的分析.
- 检查在获得息护理服务时的健康公平问题.
主要成果:
- 过度强调迷幻药物可能会膨胀感知到的证据,并从已建立的息治疗计划中转移资源.
- 解决人口层面在获得包括心理社会支持在内的综合性息护理方面的不平等问题是更紧迫的政策优先事项.
- 公平考虑必须成为任何关于扩大对迷幻疗法的访问权限的讨论的核心.
结论:
- 需要一个平衡的政策方法来解决生命结束时的心理痛苦,将有前途的新疗法与强大,公平的现有息护理接入相结合.
- 未来的政策讨论必须优先考虑健康公平,以确保所有患者都能从高质量的终身护理中受益.
更多相关视频
06:42Continuous Theta Burst Stimulation of the Posterior Medial Frontal Cortex to Experimentally Reduce Ideological Threat Responses
Published on: September 28, 2018
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
相关概念视频
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Psychedelic Agents
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Kubler Ross's Stages of Dying
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Ethical Dilemmas II
